Literature DB >> 16930777

The 5-lipoxygenase enzymatic pathway in the mouse brain: young versus old.

Cinzia M Chinnici1, Yuemang Yao, Domenico Praticò.   

Abstract

The 5-lipoxygenase (5-LO) pathway of arachidonic acid metabolism is an important source of inflammatory mediators, and is also present in the central nervous system. In this study, we assayed the expression levels and activity of 5-LO in different brain regions of young versus old C57Bl/6 mice. 5-LO mRNA was expressed in all the brain regions considered, i.e. cortex, hippocampus, and cerebellum. The highest expression level was observed in cerebellum compared with cortex and hippocampus, although it was not affected by aging. By contrast, 5-LO mRNA and protein levels were significantly increased in the hippocampus of old (25 months) versus young (3 months) mice. Finally, levels of the leukotriene B4, a metabolic product of 5-LO, were significantly increased in the hippocampus of old mice, but no difference was observed in cortex and cerebellum. These results demonstrate that the 5-LO enzymatic pathway is widely expressed in the mouse CNS, where significant changes are region-specific and age-dependent. This observation supports the hypothesis that 5-LO may be involved in diseases of the brain associated with aging.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16930777     DOI: 10.1016/j.neurobiolaging.2006.06.007

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  52 in total

1.  Effects of minocycline on cocaine sensitization and phosphorylation of GluR1 receptors in 5-lipoxygenase deficient mice.

Authors:  Hu Chen; Hari Manev
Journal:  Neuropharmacology       Date:  2010-09-22       Impact factor: 5.250

2.  5-lipoxygenase as an endogenous modulator of amyloid β formation in vivo.

Authors:  Jin Chu; Domenico Praticò
Journal:  Ann Neurol       Date:  2010-11-17       Impact factor: 10.422

3.  Increased 5-lipoxygenase immunoreactivity in the hippocampus of patients with Alzheimer's disease.

Authors:  Milos D Ikonomovic; Eric E Abrahamson; Tolga Uz; Hari Manev; Steven T Dekosky
Journal:  J Histochem Cytochem       Date:  2008-08-04       Impact factor: 2.479

4.  Modulation of multiple pathways involved in the maintenance of neuronal function during aging by fisetin.

Authors:  Pamela Maher
Journal:  Genes Nutr       Date:  2009-09-10       Impact factor: 5.523

5.  5-Lipoxygenase gene transfer worsens memory, amyloid, and tau brain pathologies in a mouse model of Alzheimer disease.

Authors:  Jin Chu; Phillip F Giannopoulos; Carolina Ceballos-Diaz; Todd E Golde; Domenico Praticò
Journal:  Ann Neurol       Date:  2012-09       Impact factor: 10.422

6.  5-Lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer's disease.

Authors:  Omidreza Firuzi; Jiamin Zhuo; Cinzia M Chinnici; Thomas Wisniewski; Domenico Praticò
Journal:  FASEB J       Date:  2007-11-12       Impact factor: 5.191

Review 7.  Novel Key Players in the Development of Tau Neuropathology: Focus on the 5-Lipoxygenase.

Authors:  Elisabetta Lauretti; Domenico Praticò
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

8.  5-Lipoxygenase and epigenetic DNA methylation in aging cultures of cerebellar granule cells.

Authors:  M Imbesi; S Dzitoyeva; L W Ng; H Manev
Journal:  Neuroscience       Date:  2009-09-22       Impact factor: 3.590

9.  The 5-lipoxygenase as a common pathway for pathological brain and vascular aging.

Authors:  Jin Chu; Domenico Praticò
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-09-01

10.  5-Lipoxygenase DNA methylation and mRNA content in the brain and heart of young and old mice.

Authors:  Svetlana Dzitoyeva; Marta Imbesi; Louisa W Ng; Hari Manev
Journal:  Neural Plast       Date:  2009-12-13       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.